Pakistani authorities are offering a reward for information about a suicide bomber who attacked a mosque in the northwest and ...

$VNDA insiders have traded $VNDA stock on the open market 5 times in the past 6 months. Of those trades, 4 have been purchases and 1 have been sales.

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), a biopharmaceutical company with a market capitalization of $262 million and impressive gross margins of 94%, disclosed recent changes to its executive ...

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), a biopharmaceutical company with a market capitalization of $262 million and impressive gross margins of 94%, disclosed recent changes ...

Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) had its price target upped by HC Wainwright from $18.00 to $20.00 in a research note issued to investors on Tuesday morning,Benzinga reports.

Ratings for Vanda Pharma VNDA were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings ...

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Vanda (VNDA – Research Report) on February 14 and set a price target of $20.00. The company’s shares closed last Friday at $4.42.

H.C. Wainwright raised the firm’s price target on Vanda Pharmaceuticals (VNDA) to $20 from $18 and keeps a Buy rating on the shares. The firm added imsidolimab to its valuation assessment.